-
Gender and racial/ethnic differences in physiologic responses in the stimulant reduction intervention using dosed exercise study.
Killeen TK, Wolf B, Greer TL, Carmody TJ, Rethorst CD, Trivedi MH. Gender and racial/ethnic differences in physiologic responses in the stimulant reduction intervention using dosed exercise study. Addictive Behaviors 2020;110:106546
-
Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: A case study.
Bobb JF, Qui H, Matthews AG, McCormack J, Bradley KA. Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: A case study. Trials 2020;21:289
-
Substance use and mental health in emerging adult vs. older adult men and women with opioid use disorder.
Barbosa-Leiker C, Campbell ANC, Pavlicova M, Scodes J, Burlew AK, Hatch-Maillette MA, Mennenga SE, Mitchell SG, Novo P, Nunes EV, Rotrosen J, Greenfield SF. Substance use and mental health in emerging adult vs. older adult men and women with opioid use disorder. American Journal on Addictions 2020;29(6):536-542.
-
Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder.
Peckham AD, Griffin ML, McHugh RK, Weiss RD. Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder. Drug and Alcohol Dependence 2020;213:108122.
-
Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among Black adults.
Haeny AM, Montgomery L, Burlew AK, Campbell ANC, Scodes J, Pavlicova M, Rotrosen J, Nunes EV. Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among Black adults. Addictive Behaviors 2020;110:106514.
-
Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol.
Critchley L, Carrico A, Gukasyan N, Jacobs P, Mandler RN, Rodriguez AE, del Rio C, Metsch LR, Feaster DJ. Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol. Addiction Science & Clinical Practice 2020;15:19.
-
Hispanic participants in the National Institute on Drug Abuse’s Clinical Trials Network: A scoping review of two decades of research.
Eghaneyan BH, Sanchez K, Haeny AM, Montgomery L, Lopez-Castro T, Burlew AK, Rezaeiadeh A, Killian MO. Hispanic participants in the National Institute on Drug Abuse's Clinical Trials Network: A scoping review of two decades of research. Addictive Behaviors Reports 2020;12:100287.
-
Dosage of booster phone calls following an SBIRT intervention in the emergency department for reducing substance use.
Hatch-Maillette MA, Donovan DM, Laschober TC. Dosage of booster phone calls following an SBIRT intervention in the emergency department for reducing substance use. Journal of Substance Abuse Treatment 2020;116:108043.
-
Crossover between diagnostic and empirical categorizations of full and subthreshold PTSD.
Morgan-Lopez AA, Killeen TK, Saavedra LM, Hien DA, Fitzpatrick S, Ruglass LM, Back SE. Crossover between diagnostic and empirical categorizations of full and subthreshold PTSD. Journal of Affective Disorders 2020;274:832-840.
-
The “Women and Trauma” study and its national impact on advancing trauma specific approaches in community substance use treatment and research.
Hien DA, Kropp FB, Wells EA, Campbell ANC, Hatch-Maillette MA, Hodgkins C, Killeen T, Lopez-Castro T, Morgan-Lopez AA, Ruglass LM, Saavedra LM, Nunes EV. The "Women and Trauma" study and its national impact on advancing trauma specific approaches in community substance use treatment and research. Journal of Substance Abuse Treatment 2020;112S:12-17.